10-KThe Record
Taysha Gene Therapies, Inc. files 10-K
Filed Mar 19, 2026 · 3mo ago · Accession 0001193125-26-115202
Plain English
Annual report — full-year financials, business overview, and risk factors.
Read the source below for the full document.
Filing details
- Company
- Taysha Gene Therapies, Inc.
- Ticker
- TSHA
- CIK
- 1806310
- Form type
- 10-K
- Filing date
- Mar 19, 2026
- Report date
- Dec 31, 2025
- Document
- tsha-20251231.htm
- Size
- 18.9 MB